Redx Pharma Sees Promising Results From Liver Disease Treatment
LONDON (Alliance News) - Redx Pharma PLC said Tuesday that preclinical efficacy data for its ROCK2 compound showed the product was able to have an impact on established fibrosis.Shares in a Read More